Press Release: Poseida Therapeutics, Inc. Announces Agreement to Be Acquired by Roche Holdings, Inc.

Dow JonesNov 26 01:10 ET

Poseida Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones54minutes ago · Ratings

Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com

Barron's11:10 ET

Poseida Therapeutics Up Nearly 225%, On Pace For Record High Close -- Data Talk

Dow JonesNov 26 10:03 ET

H.C. Wainwright Downgrades Poseida Therapeutics(PSTX.US) to Hold Rating, Cuts Target Price to $9

Moomoo NewsNov 26 09:32 ET · Ratings

Shareholder Alert: Ademi LLP Investigates Whether Poseida Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

BusinesswireNov 26 09:22 ET